Zinc oxide is commonly used in sunscreens and skin-protectant products because it can filter ultraviolet radiation and help form a protective barrier on the skin. However, finding zinc oxide on an ingredient list does not tell you how well the finished product will perform. Its effect depends on the material grade, formulation, test method, and intended use. This article explains its well-supported functions, the limits behind broader skin claims, and what to evaluate before formulation testing.
What Does Zinc Oxide Actually Do in Skin Products?
The most reliable zinc oxide benefits for skin come from two well-established roles in finished products. First, it can work as an inorganic ultraviolet filter in a properly formulated and tested sunscreen. Second, it can work as a skin protectant in products designed to form a barrier over irritated or exposed skin.
These roles do not make every product containing zinc oxide a sunscreen or a skin treatment. A raw material has physical and chemical properties; a finished product has a formula, dose, method of use, test result, label, and regulatory category. You must evaluate those two levels separately.
This distinction also explains why a long list of “zinc oxide benefits” can be misleading. Claims such as acne treatment, oil control, pore reduction, whitening, or wound healing require their own evidence. You cannot infer them from the ingredient name alone. A better question is not only “What can zinc oxide do?” but also “Under which formulation, test, and use conditions has that function been demonstrated?”
UV Protection Is Its Best-Established Skin Benefit
It Helps Formulations Cover UVA and UVB
Zinc oxide is widely used in broad-spectrum sunscreen systems because its optical response extends across UVB and UVA wavelengths. It may be used alone or alongside other permitted UV filters, depending on the market and formulation strategy.
The important point is that broad-spectrum protection belongs to the finished sunscreen, not automatically to the zinc oxide powder. Zinc oxide concentration, particle characteristics, dispersion quality, film uniformity, other UV filters, and the quantity applied all influence the final result. You therefore need the required SPF, UVA, critical-wavelength, water-resistance, or equivalent finished-product tests for the market in which the product will be sold.
The US FDA sunscreen monograph lists zinc oxide at up to 25% as an active ingredient under its specified conditions. This is a regulatory ceiling, not a recommended use level or a guaranteed SPF. The monograph also connects the finished product with defined test and labelling requirements. Set the target market and protection claim before selecting a material grade, rather than choosing a percentage first and inventing the claim later. (FDA OTC Monograph M020)
Zinc Oxide Mainly Absorbs UV Rather Than Simply Reflecting It
Zinc oxide is often described as a “physical blocker” that sits on the skin and reflects UV like a mirror. That description is easy to remember, but it is not an accurate account of its main protective mechanism in the ultraviolet range.
Optical research comparing absorption, reflection, and scattering found that zinc oxide and titanium dioxide provide most of their UV protection through absorption. Reflection and scattering still occur, especially as wavelength and material characteristics change, but they are not the main reason these materials protect across the UV range. In the cited study, average reflection across the UV range was only 4%–5%. (Cole, Shyr and Ou-Yang, 2016)
You can still use “mineral sunscreen” as a familiar product category. The problem begins when technical training or marketing material turns “mineral” into the absolute claim that the filter only reflects radiation and never absorbs it. A more accurate explanation is: zinc oxide interacts with incoming light through absorption, scattering, and reflection, with UV protection arising primarily from absorption. This wording is both understandable and consistent with the measured optical behaviour.
It Can Also Act as a Skin Protectant—but Context Matters
Barrier Products Can Help Keep Moisture and Irritants Away
A zinc oxide cream, ointment, or paste can be formulated to protect the skin surface. In these products, the formula forms a physical layer that helps separate the skin from moisture, friction, or external irritants. Diaper-rash products are a familiar example: the practical value comes from protecting chafed or irritated skin and helping seal out wetness.
The US FDA skin-protectant monograph lists zinc oxide at 1%–25%, and above 25% to 40% in an ointment dosage form, under its specified conditions. It also provides defined labelling routes for products intended to help treat or prevent diaper rash and protect skin from wetness. These are conditions for correctly formulated and labelled finished OTC products. They are not permission to describe any bulk zinc oxide powder as a product that treats diaper rash. (FDA OTC Monograph M016)
When you evaluate a barrier-product concept, consider the whole vehicle. Zinc oxide content matters, but so do coverage, persistence, rheology, preservation, packaging, and directions for use.
Wound and Irritation Claims Need Narrow Language
Zinc-containing preparations have been studied in some wound-care, ulcer, and dressing contexts. That does not establish “heals damaged skin” as a general property of every cosmetic formula containing zinc oxide. Different studies may involve different zinc compounds, concentrations, vehicles, patient groups, wound types, and clinical care procedures.
You should treat terms such as “wound healing,” “treats eczema,” “repairs rosacea,” or “post-procedure recovery” as separate claim projects. First determine whether the intended product is a cosmetic, OTC drug, medical device, medicine, or another regulated category in the target market. Then match the formula, evidence, label, and quality system to that category. If you only have evidence for surface protection, say that the product helps form a protective barrier; do not upgrade that evidence into a treatment claim.
Several Popular Claims Go Beyond the Evidence
Acne, Oil Control, and Pore Claims
Searches for zinc oxide for acne often mix together evidence for different forms of zinc. Research may involve oral zinc, zinc salts, combination treatments, or medical preparations, so you cannot transfer every finding to cosmetic-grade ZnO powder. A review of zinc in acne treatment illustrates this range of zinc forms and treatment contexts; it does not prove that zinc oxide in any skincare formula treats acne. (Cervantes et al., 2018)
The same evidence gap applies to oil control and pore reduction. A powder may change a formula’s immediate finish, but this does not prove a biological reduction in sebum production or pore size. “Non-comedogenic” is also a finished-formula claim, not an automatic raw-material property.
If acne-prone skin is part of the product concept, define and test the finished-formula claim. Until then, limit zinc oxide’s stated role to the function actually established in the formula.
Antimicrobial and Anti-Inflammatory Claims
Zinc oxide can show antimicrobial activity under laboratory conditions. The result can change with particle characteristics, concentration, zinc-ion release, light, pH, and other ingredients. One formulation study demonstrated such ingredient interactions, so material activity cannot simply be copied onto a finished-product claim. (Pasquet et al., 2015)
An in-vitro result does not support an antimicrobial claim on human skin or prove that ZnO can replace preservation. You still need microbiological risk assessment and suitable finished-product challenge testing.
“Anti-inflammatory” and “soothing” require the same discipline. You should identify the exact zinc material, dose, vehicle, endpoint, and population used in the evidence. If the support comes from another zinc salt or from a medicated combination, it should not be presented as proof for ordinary zinc oxide.
Whitening and Hyperpigmentation Claims
A successful sunscreen can help reduce further UV exposure, which is relevant when you want to manage the appearance of uneven pigmentation. That indirect preventive role is not the same as zinc oxide actively lightening existing pigment.
As a white pigment, zinc oxide may create temporary visible coverage. Do not describe this as biological whitening. Brightening or hyperpigmentation claims need evidence for the complete formula and stated endpoint.
A practical way to control all these claims is to build a claim-to-evidence table. For every proposed sentence, record the exact material, finished formula, test method, population, market, permitted wording, and source. If a critical cell is empty, the claim remains pending rather than becoming marketing copy.
The Same Zinc Oxide Can Perform Differently in Different Formulas
Particle Size Must Be Read with Its Test Method
A specification such as “30 nm zinc oxide” may describe primary crystallites, particles, aggregates, or agglomerates. It could be an average or percentile measured by microscopy, laser diffraction, dynamic light scattering, or another method, and calculated by number, volume, or intensity. These results are not interchangeable.
D50 means that 50% of the measured distribution falls below a stated diameter, but you still need its calculation basis and sample preparation. Small primary particles may form much larger agglomerates after poor wetting, while processing may break loose agglomerates without changing primary crystal size.
When you compare zinc oxide particle size, request the full distribution, test method, sample preparation, and basis of calculation. Compare the supplier’s measurement with the state that matters in your formula. A single average cannot independently prove transparency, SPF contribution, skin safety, dispersibility, or regulatory suitability.
Surface Treatment Changes Compatibility and Handling
Surface treatment can change wetting, surface reactivity, dispersion, feel, and stability. Its value depends on the treatment chemistry and the formula in which the material is used.
“Surface treated” is incomplete purchasing information. Request the treatment identity, level or specification, complete INCI, and processing guidance. A grade designed for an oil phase may perform poorly in water, while a useful coating may conflict with another emulsifier or regulatory condition.
You should also check whether the named coating and the coated material match the permitted conditions in the target market. Do not assume that all coated nano zinc oxide grades share the same regulatory status.
Powder and Dispersion Solve Different Formulation Tasks
Powder gives you control over the carrier and final ZnO loading, but transfers wetting and dispersion to your process. You may need a suitable dispersant, sufficient shear, controlled addition, dust management, and a method to check agglomerates.
A ready-made dispersion may shorten this work, but “pre-dispersed” does not mean universally compatible or permanently stable. Before comparison, you need to know:
- the zinc oxide percentage and how it is measured;
- the complete carrier and dispersant composition;
- the surface treatment on the ZnO, if any;
- viscosity, density, pH, and particle-size data;
- preservative system and microbiological specification where relevant;
- recommended phase, temperature, shear, and addition sequence;
- storage conditions, shelf life, and sedimentation or redispersion behaviour.
Distinguish a dispersion, which contains particles in a medium, from a dispersant, which helps wet and stabilize particles. Confusing them can cause calculation, declaration, and compatibility errors.
Compare powder and dispersion on an equivalent-ZnO basis. If a dispersion contains 40% ZnO, adding 20% of that dispersion contributes only 8% ZnO before considering the rest of the formulation. You must also include the carrier and other components in the formula and label calculation.
Film Quality and Finished-Product Testing Decide the Result
In any zinc oxide formulation, even a well-characterized grade can perform poorly in an unsuitable system. UV filters need to be distributed through a stable formula and form sufficiently uniform coverage after application. Agglomeration, sedimentation, uneven spreading, incompatibility, or crystallization can create weak areas in the film. These problems may reduce protection or create unacceptable white cast and texture.
Other components also change the result: film formers affect persistence, oils affect wetting, pigments change visible whiteness, and other UV filters alter spectral balance. Packaging and application instructions affect the applied amount.
This is why supplier UV spectra, a theoretical SPF calculator, or an in-vitro screening result should be used for development—not as a substitute for the finished tests required for your claim and market. Your comparison table should place composition, particle data, coating, dispersion state, processing, stability, sensory results, and finished efficacy in the same decision record.
Nano and Non-Nano Are a Trade-Off, Not a Quality Ranking
Smaller zinc oxide particles can reduce visible scattering and may help a sunscreen look less white. Yet white cast is not controlled by a Nano/Non-Nano label alone. Particle-size distribution, agglomeration, coating, concentration, film thickness, skin tone, and pigments all affect the visible result.
Nano-scale features also change the evidence you need. A safety assessment may need to consider particle identity, morphology, surface area, solubility, surface treatment, aggregation, exposure route, and the difference between intact particles and dissolved zinc species. Human research on specific sunscreen formulations found ZnO nanoparticles mainly at the skin surface and furrows rather than in the viable epidermis, while also distinguishing the release and penetration of zinc ions. Other experimental work shows that barrier condition, exposure time, and vehicle can influence zinc found within skin. These findings support a material- and use-specific assessment, not the absolute statement “nano particles never penetrate.” (Mohammed et al., 2019; Holmes et al., 2020)
EU Regulation 2016/621 permits Zinc Oxide and Zinc Oxide (nano) as UV filters up to 25% under stated conditions and excludes applications that may expose the end user’s lungs by inhalation. For Nano ZnO, it also specifies characteristics including purity, wurtzite structure, number-based D50 and D1 limits, water solubility, and permitted coating conditions. You cannot demonstrate compliance with these conditions using an unspecified “average particle size” alone. (Commission Regulation (EU) 2016/621)
Start with exposure route and target market. A non-spray cream and an aerosolizable powder do not present the same inhalation question. Then compare the exact material dossier with the applicable requirements. Choose Nano or Non-Nano because it fits the finished product, evidence package, and market—not because one label sounds more advanced or more natural.
How to Evaluate a Zinc Oxide Grade Before Formulation Testing
Step 1: Define the Finished Product and Market
Record the product form, intended use, target countries, regulatory category, proposed claims, possible inhalation exposure, and required finished-product tests. A daily cosmetic, OTC sunscreen, colour cosmetic, diaper-rash ointment, and loose powder do not follow the same evidence path.
This prevents you from approving a brochure claim before checking whether the composition, coating, and documents fit the actual market.
Step 2: Define the Performance Target
Convert general goals into measurable targets. Instead of asking for “high UV protection with no white cast,” define the intended SPF and UVA claims, water resistance, acceptable colour shift on relevant skin tones, viscosity range, sensory profile, and stability conditions.
Document the formulation system, temperature, available shear, dispersants, pigments, film formers, and packaging. A grade is only useful if you can process it consistently in that system.
Step 3: Compare Material Identity, Not Marketing Labels
Create one comparison table for every candidate. At minimum, include:
- grade code, manufacturer, INCI, and complete composition;
- ZnO purity, relevant impurities, and crystal form;
- primary-particle information and full particle-size distribution;
- measurement method, sample preparation, and number/volume/intensity basis;
- surface-treatment identity and amount;
- powder or dispersion form;
- for a dispersion, carrier, dispersant, ZnO loading, rheology, and preservation;
- applicable regulatory statements and supporting documents.
Terms such as “cosmetic grade,” “high purity,” “non-nano,” or “easy to disperse” should lead to a definition and test report. They should not receive an automatic score in the comparison.
Step 4: Run Formulation and Stability Tests
Begin with a controlled laboratory formula and record the addition sequence, temperature, shear, time, and equipment. Examine initial dispersion, viscosity, colour, pH where relevant, application uniformity, and white cast. Then assess sedimentation, agglomeration, viscosity drift, odour, colour change, and packaging compatibility under a justified stability protocol.
For a sunscreen concept, use development screening to compare candidates, but complete the required finished-product SPF, UVA, water-resistance, safety, and other claim tests before approving market statements. For a barrier product, test the properties linked to its actual claim and dosage form. A material that performs well in one benchmark formula may still fail in another.
Step 5: Approve the Commercial Grade Only After Evidence Review
Do not approve a commercial grade from one successful sample alone. Compare the sample identification and COA with the proposed purchasing specification. Define acceptable limits for the critical properties that affected your trial, and confirm how the supplier controls them from batch to batch.
Keep an approved reference sample where appropriate, specify change-notification expectations, and decide which incoming checks are required. Reassess the material if the manufacturing site, coating, particle specification, carrier, dispersant, or test method changes. This connects formulation success with repeatable supply rather than a one-time laboratory result.
What to Request from a Zinc Oxide Supplier
A useful supplier response should let you identify the material, assess its market fit, reproduce the formulation trial, and control future batches. Request the documents and data that answer those tasks:
- Product name, grade code, manufacturer, INCI, and complete composition.
- Current TDS, SDS, representative COA, and proposed purchasing specification.
- Particle-size distribution with method, sample preparation, calculation basis, and original report where needed.
- Crystal form, ZnO purity, relevant impurities, heavy-metal limits, and the methods used.
- Surface-treatment identity, amount or specification, and corresponding ingredient declaration.
- For a dispersion: carrier, dispersant, ZnO loading, viscosity, density, pH, preservative system, and microbiological limits as applicable.
- Regulatory statements for the named grade and target market, with the documents supporting those statements.
- Recommended incorporation method, handling precautions, storage conditions, shelf life, and sample availability.
- Batch-control limits, change-notification policy, and how a development sample will be matched to commercial supply.
- A clear statement of which performance claims require testing in your finished formula.
Send the supplier your application, product form, target market, performance target, formulation phase, and required documents. That information is more useful than asking for “the best zinc oxide for skin.” It allows both sides to screen unsuitable options before time is spent on samples.
At the current evidence stage, no specific KOSNANO grade should be presented in this article as automatically suitable for a sunscreen or other skin product. A responsible next step is to compare the intended application and market with the complete grade dossier, then shortlist a candidate for formulation testing. Product selection should follow the evidence, not precede it.
Frequently Asked Questions
1. Does zinc oxide protect against both UVA and UVB?
Yes, zinc oxide can contribute protection across UVA and UVB wavelengths when used in a properly formulated sunscreen. However, the ingredient name or use percentage does not prove the finished protection level. Dispersion, particle characteristics, film uniformity, other filters, and applied amount all affect performance. Check the finished product’s SPF, UVA or broad-spectrum testing and confirm that the test method and claim meet the target market’s requirements.
2. Does zinc oxide reflect or absorb UV radiation?
Zinc oxide interacts with light through absorption, scattering, and reflection, but research shows that its UV protection comes mainly from absorption rather than mirror-like reflection. Reflection becomes more relevant at some longer wavelengths and also contributes to visible whiteness. You can call it a mineral UV filter, but describing it as a purely physical shield that only reflects UV is technically inaccurate and should be avoided in product training or marketing.
3. Is zinc oxide safe for sensitive skin?
Many mineral sunscreens containing zinc oxide are selected for sensitive-skin products, but no raw ingredient guarantees that every finished formula will be well tolerated. Fragrance, preservatives, surfactants, other filters, dosage form, and individual skin conditions can change the response. Evaluate safety and tolerability using the complete formula and intended use. Anyone with persistent irritation, a diagnosed skin condition, or a reaction to a product should seek appropriate medical advice. (American Academy of Dermatology)
4. Can zinc oxide be used on the face every day?
A finished facial product containing zinc oxide may be designed for daily use if it has been assessed, tested, and labelled for that purpose. Do not apply industrial powder or a cosmetic raw material directly to your face. Follow the finished product’s directions, including application amount and reapplication instructions for sunscreen. Daily suitability still depends on the complete formula, your skin response, and whether the product provides the tested protection or function you expect. (AAD sunscreen guidance)
5. Does zinc oxide help acne?
Zinc oxide should not automatically be described as an acne treatment. Studies of “zinc and acne” include oral zinc, different zinc salts, combination treatments, and early experimental work, so their findings do not all apply to ordinary ZnO skincare. A zinc oxide sunscreen may help reduce UV exposure, but that is a different function. Acne, oil-control, non-comedogenic, or lesion-reduction claims require suitable evidence from the complete finished formula.
6. Does zinc oxide heal damaged skin?
Zinc oxide can help form a protective surface layer in correctly formulated skin-protectant creams, ointments, or pastes. Specific zinc preparations have also been studied in some wound-care settings. Neither fact proves that any cosmetic containing zinc oxide heals wounds or repairs every type of damaged skin. Use narrow wording that matches the product category and evidence. Open wounds, infection, severe irritation, or persistent symptoms require advice from an appropriate healthcare professional.
7. What is the difference between nano and non-nano zinc oxide?
The distinction concerns particle dimensions, but a Nano or Non-Nano label alone does not predict performance or safety. Smaller particles may reduce visible white cast, while dispersion, coating, concentration, and film structure also matter. Nano materials can require additional characterization, notification, labelling, and exposure assessment depending on the market. Compare the full particle-size method, material dossier, product form, inhalation potential, and applicable regulation before selecting either option.
8. Why does zinc oxide leave a white cast?
Zinc oxide particles scatter visible light, which can make a film appear white, especially at higher loadings or when particles are poorly dispersed. The result also depends on particle-size distribution, agglomeration, coating, vehicle, film thickness, application amount, pigments, and skin tone. Do not judge white cast from a powder specification alone. Test the finished formula on relevant skin tones after realistic application and after the film has dried.
9. Is zinc oxide powder the same as zinc oxide dispersion?
No. Powder is the solid material and requires your process to wet, disperse, and control its agglomeration and dust. A dispersion contains zinc oxide already distributed in a liquid medium with other components. It may simplify processing but adds a carrier, dispersant, and sometimes preservatives to your formula. Compare options on an equivalent-ZnO basis and verify the dispersion’s complete composition, loading, viscosity, compatibility, stability, and incorporation method.
10. What data should you request from a zinc oxide supplier?
Request the grade identity, INCI and complete composition, current TDS, SDS, COA, purchasing specification, purity, relevant impurities, crystal form, and full particle-size distribution with its method. Confirm any surface treatment and, for a dispersion, its carrier, dispersant, ZnO loading, rheology, and preservation. You should also obtain market-specific regulatory support, processing guidance, storage information, batch-control limits, change-notification terms, and clarity on which claims require finished-product testing.
Final Thoughts
Zinc oxide can provide reliable UV filtration and skin-protective functions, but those benefits only become meaningful when the material fits the formula, market, and finished-product evidence. Before selecting a grade, define your application, product form, target market, performance goals, and required documents. Share those details with us so we can compare the relevant particle data, surface treatment, composition, and regulatory support, then identify a candidate for your own formulation and finished-product testing.